Evaluating the Efficacy of Machine Performance Checks as an Alternative to Winston–Lutz Quality Assurance Testing in the TrueBeam Linear Accelerator with HyperArc

Abstract

HyperArc is a preferred technique for treating brain metastases, employing a single isocenter for multiple lesions. Geometrical isocentricity in the TrueBeam linear accelerator with HyperArc is crucial. We evaluated machine performance checks (MPCs) as an alternative to the Winston–Lutz (WL) test to verify the treatment isocenter. Between January and July 2023, we assessed 53 data points using MPC and Winston–Lutz tests. The isocenter size obtained from the MPC and its sum, including the rotation-induced couch shift, were compared with the maximum total delta value from the Winston–Lutz test. The maximum total delta was 0.68 ± 0.10 mm, while the isocenter size was 0.28 ± 0.02 mm. The sum of the isocenter size and rotation-induced couch shift measured by MPC was 0.61 ± 0.03 mm. During the Winston–Lutz test (without couch rotation), the maximum total delta value was 0.56 ± 0.13 mm. A t-test analysis revealed a significant difference in the isocenter size averages between the Winston–Lutz and MPC outcomes, whereas the Pearson’s correlation coefficient yielded no correlation. Our study highlights the necessity for separate MPC and Winston–Lutz tests for isocenter verification. Therefore, the Winston–Lutz test should precede stereotactic radiosurgery for isocenter verification.

Keywords

• isocenter
• HyperArc technique
• brain metastasis
• machine performance check
• Winston–Lutz test
• TrueBeam linear accelerator